Live-Cell Imaging of Protease Activity: Assays to Screen Therapeutic Approaches.
Methodologies to image and quantify the activity of proteolytic enzymes have been developed in an effort to identify protease-related druggable pathways that are involved in malignant progression of cancer. Our laboratory has pioneered techniques for functional live-cell imaging of protease activity in pathomimetic avatars for breast cancer. We analyze proteolysis in the context of proliferation and formation of structures by tumor cells in 3-D cultures over time (4D). In order to recapitulate the cellular composition and architecture of tumors in the pathomimetic avatars, we include other tumor-associated cells (e.g., fibroblasts, myoepithelial cells, microvascular endothelial cells). We also model noncellular aspects of the tumor microenvironment such as acidic pericellular pH. Use of pathomimetic avatars in concert with various types of imaging probes has allowed us to image, quantify, and follow the dynamics of proteolysis in the tumor microenvironment and to test interventions that impact directly or indirectly on proteolytic pathways. To facilitate use of the pathomimetic avatars for screening of therapeutic modalities, we have designed and fabricated custom 3D culture chambers with multiple wells that are either individual or connected by a channel to allow cells to migrate between wells. Optical glass microscope slides underneath an acrylic plate allow the cultures to be imaged with an inverted microscope. Fluid ports in the acrylic plate are at a level above the 3D cultures to allow introduction of culture media and test agents such as drugs into the wells and the harvesting of media conditioned by the cultures for immunochemical and biochemical analyses. We are using the pathomimetic avatars to identify druggable pathways, screen drug and natural product libraries and accelerate entry of validated drugs or natural products into clinical trials.
Department of Pharmacology, School of Medicine, Wayne State University, Detroit, MI, 48201, USA.
Anita
A
Chalasani
Department of Pharmacology, School of Medicine, Wayne State University, Detroit, MI, 48201, USA.
Kyungmin
K
Ji
Department of Pharmacology, School of Medicine, Wayne State University, Detroit, MI, 48201, USA.
Mansoureh
M
Sameni
Department of Pharmacology, School of Medicine, Wayne State University, Detroit, MI, 48201, USA.
Samia H
SH
Mazumder
Department of Electrical and Computer Engineering, Wayne State University, Detroit, MI, 48202, USA.
Yong
Y
Xu
Department of Pharmacology, School of Medicine, Wayne State University, Detroit, MI, 48201, USA.
Kamiar
K
Moin
Department of Pharmacology, School of Medicine, Wayne State University, Detroit, MI, 48201, USA. bsloane@med.wayne.edu.
Bonnie F
BF
Sloane
D001681:Biological Assay / Q000379:methods*; D018929:Cell Culture Techniques; D045744:Cell Line, Tumor; D055808:Drug Discovery / Q000379:methods*; D004353:Drug Evaluation, Preclinical; D004789:Enzyme Activation / Q000187:drug effects; D015870:Gene Expression; D017930:Genes, Reporter; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008164:Luminescent Proteins / Q000235:genetics / Q000378:metabolism; D018613:Microscopy, Confocal; D057054:Molecular Imaging / Q000379:methods*; D010447:Peptide Hydrolases / Q000378:metabolism*; D059748:Proteolysis; D012984:Software
D008164:Luminescent Proteins; D010447:Peptide Hydrolases
Confocal microscopy; Fluorescent imaging; High-content imaging; Proteolysis; Screening assays